NASDAQ:NVCR

Novocure Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy NVCR

*Your capital is at risk

$16.15

+0.330 (+2.09%)

At Close: Jun 03, 2026

NovoCure Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 34.29. In total, the insiders bought 2.79M and sold 223.1K NVCR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	34.29
● Buy	2.79M shares
● Sell	223.1K shares
76% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence Mar 05, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 34.29. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 05, 2025 Buy	Ordinary Shares P-Purchase	Cordova Ashley Chief Executive Officer	CEO / President	81 550 Value: $996.9K
Sep 05, 2025 Buy	Ordinary Shares P-Purchase	Cordova Ashley Chief Executive Officer	CEO / President	81 550 Value: $996.9K
Jul 29, 2025 Buy	Ordinary Shares P-Purchase	Brackmann Christoph Chief Financial Officer	C-Suite Officer	5 000 Value: $57.5K
Jul 29, 2025 Buy	Ordinary Shares P-Purchase	Brackmann Christoph Chief Financial Officer	C-Suite Officer	5 000 Value: $58.0K
Jul 29, 2025 Buy	Ordinary Shares P-Purchase	Brackmann Christoph Chief Financial Officer	C-Suite Officer	10 000 Value: $116.3K
Jul 29, 2025 Buy	Ordinary Shares P-Purchase	Brackmann Christoph Chief Financial Officer	C-Suite Officer	10 000 Value: $116.3K
Jul 29, 2025 Buy	Ordinary Shares P-Purchase	Brackmann Christoph Chief Financial Officer	C-Suite Officer	5 000 Value: $58.0K
Jul 29, 2025 Buy	Ordinary Shares P-Purchase	Brackmann Christoph Chief Financial Officer	C-Suite Officer	5 000 Value: $57.5K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Puri Michal Nath Chief Human Resources Officer	Officer	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Leonard Frank X EVP, Pres., Novocure Oncology	Officer	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Danziger Asaf Director	Director	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Cordova Ashley Chief Executive Officer	CEO / President	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Ben Arye Barak General Counsel	Officer	769 Value: $11.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Ben Arye Barak General Counsel	Officer	769 Value: $11.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Cordova Ashley Chief Executive Officer	CEO / President	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Danziger Asaf Director	Director	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Leonard Frank X EVP, Pres., Novocure Oncology	Officer	833 Value: $12.6K
Jun 30, 2025 Buy	Ordinary Shares A-Award	Puri Michal Nath Chief Human Resources Officer	Officer	833 Value: $12.6K
Jun 04, 2025 Buy	Ordinary Shares A-Award	Leung Gabriel Director	Director	11 215 Value: $187.5K
Jun 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Leung Gabriel Director	Director	16 697 Value: $279.2K
Jun 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Stafford Kristin Director	Director	16 697 Value: $279.2K
Jun 04, 2025 Buy	Ordinary Shares A-Award	Stafford Kristin Director	Director	11 215 Value: $187.5K
Jun 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Madden Martin J. Director	Director	33 393 Value: $558.3K
Jun 04, 2025 Buy	Ordinary Shares A-Award	Hilleman Jeryl L Director	Director	11 215 Value: $187.5K
Jun 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Hilleman Jeryl L Director	Director	16 697 Value: $279.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVOCURE LIMITED

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c...

Read Full Profile Here